![]() |
![]() |
Your cart is empty |
||
Showing 1 - 1 of 1 matches in All Departments
This authoritative and comprehensive book makes the reader familiar
with the processes of bringing orphan drugs to the global market.
There are between 5,000 and 7,000 rare diseases and the number of
patients suffering from them is estimated to be more than 50
million in the US and Europe. Before the orphan drug legislation
enacted in the US in 1983, there was a limited interest from
industry to develop treatment for very small patient groups. One of
the difficulties is, of course, that similar levels of investment
are needed from a pharmaceutical company to bring a drug to the
market for both small and large patient groups.
|
![]() ![]() You may like...
100 Most Successful Women Around The…
Maria-Renee Davila, Caroline Makaka
Paperback
Die Singende Hand - Versamelde Gedigte…
Breyten Breytenbach
Paperback
Notes on Drawings by Mr. Ruskin Placed…
Charles Eliot Norton
Paperback
An Introduction to the Study of English…
Ansgar Nunning, Vera Nunning
Paperback
R442
Discovery Miles 4 420
Reading From The South - African Print…
Sarah Nuttall, Charne Lavery
Paperback
|